A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult Participants
NCT06849791 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 9
Last updated 2026-02-24
Summary
This study will assess the relative bioavailability and effect of food on pharmacokinetics of ABBV-932 oral administration in healthy adult participants.
Conditions
- Healthy Volunteer
Interventions
- DRUG
-
ABBV-932
Oral tablet
- DRUG
-
ABBV-932
Oral Capsule
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
ABBVIE INC. · AbbVie
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-02-26
- Primary Completion
- 2026-03-31
- Completion
- 2026-03-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate Adverse Events, How the Drug is Tolerated, and How the Drug Moves Through the Body of Intravenous Infusions of ABBV-8736 in Adult Healthy Volunteers
NCT07141199 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult Asian Participants
NCT06673238 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase 1 Study Assessing the Effect of Food on the Pharmacokinetics of ABBV- CLS-7262
NCT06145607 ·Status: COMPLETED ·Phase: PHASE1
-
Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female Subjects
NCT01053520 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Relative Bioavailability of BMS-986435 Formulations in Healthy Adult Participants
NCT06577259 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study
NCT01602887 ·Status: COMPLETED ·Phase: PHASE1
-
Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect
NCT02071121 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of ABT-333 Within the Gastrointestinal Tract in Healthy Subjects
NCT02052349 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Food Effect of Venetoclax New Tablet Formulation in Healthy Female Participants
NCT06070948 ·Status: WITHDRAWN ·Phase: PHASE1
-
Relative Bioavailability Study in Healthy Subjects
NCT00924911 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 1291583 is Taken up by the Body
NCT06166992 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioavailability and Pharmacokinetic Study of Subcutaneous and Intravenous RO6811135 in Healthy Volunteers
NCT01802853 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability Study of K0706 in Healthy Subjects
NCT03316820 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of a BI 187004 Tablet Formulation in Comparison With an Oral Solution and the Influence of Food on the Tablet Formulation in Healthy Volunteers
NCT02161432 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to Test How 2 Different Doses of BI 1291583 Are Taken up in the Body When Given in 3 Different Formulations
NCT06631417 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Bioavailability and Food Effects of Oral Venetoclax New Tablet Formulation 2.0 in Healthy Adult Female Participants
NCT06742086 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administration With On-Body Injector in Healthy Adult Participants
NCT06937619 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioavailability Study of MIV-711 Oral Formulations in Healthy Volunteers
NCT03443453 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Absolute Bioavailability of BIIB122/DNL151 in Healthy Subjects
NCT05005338 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 BA Study, Single Center With Healthy Volunteers
NCT00870948 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants
NCT07226817 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult Participants
NCT05963932 ·Status: COMPLETED ·Phase: PHASE1
-
A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions
NCT00863941 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of Two Formulations of Risankizumab Following Subcutaneous Administration With Prefilled Syringes in Healthy Adult Participants
NCT06571266 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Adverse Events and How Oral ABBV-990 Moves Through the Body of Adult Healthy Participants
NCT05475821 ·Status: TERMINATED ·Phase: PHASE1